• <td id="602w4"></td>
  • <noscript id="602w4"><noscript id="602w4"></noscript></noscript>
    <wbr id="602w4"><td id="602w4"></td></wbr>
  • 日本語中文

    ABOUT HUAWEI HEALTH

           Established in 1992, Huawei Pharmaceutical Group is a joint venture affiliated to National Health Commission of the People’s Republic of China (the original Ministry of Health P. R. China). In the initial period of founding, it only guaranteed the pharmaceutical security of the Leading Cadre and various ministries and commissions. After over 2 decades of development, it has engaged in 4 major fields, including medicine sales, medical consulting, pharmaceutical consulting and new product technology development to urge the health undertaking of the Chinese people, medical and healthcare services and international exchanges, so as to strive for the great goal of Healthy China.

    1992

    Founded in 1992

    29

    After 29 years of development

    4

    4 business development sectors

    Past leadership

    1991-2000 Chairman, legal person
    Cao Ronggui
    Cao Ronggui,
    Deputy Direct General of the Ministry of Health
    2000-2006 Chairman, legal person
    Xue Xiaolin
    Xue Xiaolin,
    Direct General
    2006-2012 Chairman, legal person
    Ma Aining
    Ma Aining,
    Direct General
    2012-Present Chairman, legal person
    Guan Qingwei

    Guan Qingwei


    Social relation:Member of the Chinese Peasants and Works Democratic Party

    Social position: Member of the Chinese Neuromodulation Society (CNMS)

    Member of the First Standing Committee of the Chinese International Exchange and Promotive Association for Medical and Health Care, Deputy Director of the Traditional Chinese Medicine Promotion Project of the National Comprehensive Hospital of Chinese Traditional Chinese Medicine Science and Technology Development Center

     

     

     


    Company Mission
    • Become an integrator, innovator and sharer in the field of Chinese Massive Health and serve our customers in health wholeheartedly

    Development history

    1992
    Registration of Beijing Huawei Industrial Corporation in 1992
    2001
    In 2001, the nature of the company changed from collective ownership to ownership by the whole people
    2011
    New business scope in 2011: Sales of chemical APIs, western medicine preparations, biological preparations, Chinese patent medicines and medical devices.
    2012
    In 2012, Guan Qingwei served as chairman
    2015
    In 2015, the registered capital increased to build strength for future development
    2016
    In 2016, the International Department was established to carry out cooperation and exchanges in Japan's overseas markets.
    2017
    In 2017, the promotion project of traditional Chinese medicine in national general hospitals was launched
    2018
    The first Sino Japanese medical and health exchange conference will be held in 2018
    2019
    In 2019, the company changed into a group
    2020
    The second China Japan medical and health exchange conference will be held in 2020
    2021
    In 2021, the three medical mutual health fund and drug comprehensive evaluation center were established
    2022

    Organizing the 2022 (third) China Japan medical and Health Exchange Conference


    Mobile phone

    Wechat

    ADD:2812/2815/2816/2817, Nanyin building, No. 2, East Third Ring North Road, Chaoyang District, Beijing
    Tel:+86-10-61006202/61006203
    Fax:+86-10-61006309
    URL:www.shouxinbaike.com 

    Copyright(C)2022,Huawei Pharmaceutical Group All Rights Reserved.
     Supported by Toocle 31fabu Copyright Notice

    国产成人免费a在线视频_国韩精品一区二区h_一本无码久本草在线中文字幕dvd_国产热a欧美热a视频在线观看